GB1400999A - Imidazo-triazine compounds and their use in therapeutic compositions - Google Patents

Imidazo-triazine compounds and their use in therapeutic compositions

Info

Publication number
GB1400999A
GB1400999A GB5375071A GB5375071A GB1400999A GB 1400999 A GB1400999 A GB 1400999A GB 5375071 A GB5375071 A GB 5375071A GB 5375071 A GB5375071 A GB 5375071A GB 1400999 A GB1400999 A GB 1400999A
Authority
GB
United Kingdom
Prior art keywords
imidazo
aerosol
group
therapeutic compositions
triazine compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5375071A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allen and Hanburys Ltd
Original Assignee
Allen and Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE791025D priority Critical patent/BE791025A/xx
Application filed by Allen and Hanburys Ltd filed Critical Allen and Hanburys Ltd
Priority to GB5375071A priority patent/GB1400999A/en
Priority to DK525172AA priority patent/DK138691B/da
Priority to ZA727532A priority patent/ZA727532B/xx
Priority to IE1433/72A priority patent/IE37046B1/xx
Priority to US00300749A priority patent/US3840537A/en
Priority to AU48191/72A priority patent/AU472127B2/en
Priority to IL40686A priority patent/IL40686A/xx
Priority to CA155,720A priority patent/CA990292A/en
Priority to SE7214358A priority patent/SE402915B/xx
Priority to FR7239498A priority patent/FR2160407B1/fr
Priority to DE2255172A priority patent/DE2255172A1/de
Priority to PH14090*UA priority patent/PH9669A/en
Priority to CH1668372A priority patent/CH594671A5/xx
Priority to ES408736A priority patent/ES408736A1/es
Priority to JP11549572A priority patent/JPS563873B2/ja
Priority to AT982372A priority patent/AT321923B/de
Priority to NL7215646A priority patent/NL7215646A/xx
Publication of GB1400999A publication Critical patent/GB1400999A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB5375071A 1971-11-19 1971-11-19 Imidazo-triazine compounds and their use in therapeutic compositions Expired GB1400999A (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
BE791025D BE791025A (fr) 1971-11-19 Composes heterocycliques
GB5375071A GB1400999A (en) 1971-11-19 1971-11-19 Imidazo-triazine compounds and their use in therapeutic compositions
DK525172AA DK138691B (da) 1971-11-19 1972-10-23 Analogifremgangsmåde til fremstilling af imidazo(5,1-f)triazinoner eller salte deraf.
ZA727532A ZA727532B (en) 1971-11-19 1972-10-23 Heterocyclic compounds
IE1433/72A IE37046B1 (en) 1971-11-19 1972-10-23 Imidazo-triazine compounds and their use in therapeutic compositions
US00300749A US3840537A (en) 1971-11-19 1972-10-25 Imidazo(5,1-f)triazinones
AU48191/72A AU472127B2 (en) 1971-11-19 1972-10-26 Heterocyclic compounds
IL40686A IL40686A (en) 1971-11-19 1972-10-27 2-amino-imidazo(5,1-f)-as-triazin-4(3h)-ones,their preparation and pharmaceutical compositions containing them
CA155,720A CA990292A (en) 1971-11-19 1972-11-01 Imidazo-triazinones
SE7214358A SE402915B (sv) 1971-11-19 1972-11-06 Forfarande for framstellning av imidazo(5,1-f)triazinoner med terapeutisk verkan
FR7239498A FR2160407B1 (enrdf_load_stackoverflow) 1971-11-19 1972-11-08
DE2255172A DE2255172A1 (de) 1971-11-19 1972-11-10 Imidazotriazinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
PH14090*UA PH9669A (en) 1971-11-19 1972-11-16 Imidazo-(5,1-f)-as-triazin-4(3h)-ones,their compositions and method of use
CH1668372A CH594671A5 (enrdf_load_stackoverflow) 1971-11-19 1972-11-16
ES408736A ES408736A1 (es) 1971-11-19 1972-11-17 Procedimiento para la preparacion de compuestos imidazo- triazinonas.
JP11549572A JPS563873B2 (enrdf_load_stackoverflow) 1971-11-19 1972-11-17
AT982372A AT321923B (de) 1971-11-19 1972-11-17 Verfahren zur herstellung von neuen imidazotriazinonen
NL7215646A NL7215646A (enrdf_load_stackoverflow) 1971-11-19 1972-11-17

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5375071A GB1400999A (en) 1971-11-19 1971-11-19 Imidazo-triazine compounds and their use in therapeutic compositions

Publications (1)

Publication Number Publication Date
GB1400999A true GB1400999A (en) 1975-07-16

Family

ID=10468856

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5375071A Expired GB1400999A (en) 1971-11-19 1971-11-19 Imidazo-triazine compounds and their use in therapeutic compositions

Country Status (18)

Country Link
US (1) US3840537A (enrdf_load_stackoverflow)
JP (1) JPS563873B2 (enrdf_load_stackoverflow)
AT (1) AT321923B (enrdf_load_stackoverflow)
AU (1) AU472127B2 (enrdf_load_stackoverflow)
BE (1) BE791025A (enrdf_load_stackoverflow)
CA (1) CA990292A (enrdf_load_stackoverflow)
CH (1) CH594671A5 (enrdf_load_stackoverflow)
DE (1) DE2255172A1 (enrdf_load_stackoverflow)
DK (1) DK138691B (enrdf_load_stackoverflow)
ES (1) ES408736A1 (enrdf_load_stackoverflow)
FR (1) FR2160407B1 (enrdf_load_stackoverflow)
GB (1) GB1400999A (enrdf_load_stackoverflow)
IE (1) IE37046B1 (enrdf_load_stackoverflow)
IL (1) IL40686A (enrdf_load_stackoverflow)
NL (1) NL7215646A (enrdf_load_stackoverflow)
PH (1) PH9669A (enrdf_load_stackoverflow)
SE (1) SE402915B (enrdf_load_stackoverflow)
ZA (1) ZA727532B (enrdf_load_stackoverflow)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009384A1 (en) * 1978-09-18 1980-04-02 Glaxo Group Limited Processes for the preparation of triazinones and condensed triazinones, and compounds so obtained
US4278673A (en) * 1977-03-25 1981-07-14 Allen & Hanburys Limited Pharmacologically active compounds
US5498774A (en) * 1989-06-23 1996-03-12 Takeda Chemical Industries, Ltd. Condensed heterocyclic compounds, their production and use
WO2016147659A1 (en) * 2015-03-16 2016-09-22 Sumitomo Dainippon Pharma Co., Ltd. Bicyclic imidazolo derivative

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1457873A (en) * 1973-01-04 1976-12-08 Allen & Hanburys Ltd Imidazotriazines
DE2314488C3 (de) * 1973-03-23 1979-01-04 C.H. Boehringer Sohn, 6507 Ingelheim 8-(2,6-Dichlorphenyl)-7-(4-chlorphenyl)-5-oxo-233,8-tetrahydro-imidazo [1,2-a] -s-triazin, Verfahren zu dessen Herstellung und dieses enthaltene Arzneimittel
DE2335193A1 (de) * 1973-07-11 1975-01-30 Hoechst Ag Bis-triazinobenzimidazole und ihre herstellung
US4107307A (en) * 1977-02-03 1978-08-15 American Cyanamid Company Imidazo [1,5-d]-as-triazine-4(3H)-ones and thiones
US4115572A (en) * 1977-02-03 1978-09-19 American Cyanamid Company Imidazo-[1,5-d]-as-triazin-1(2H)-ones and method of ameliorating asthma
USRE30511E (en) * 1977-02-03 1981-02-10 American Cyanamid Company Imidazo[1,5-d]-as-triazine-4(3H)-ones and thiones
US4107308A (en) * 1977-10-18 1978-08-15 American Cyanamid Company Imidazo[1,5-d]-as-triazines
HU187474B (en) * 1981-11-18 1986-01-28 Gyogyszerkutato Intezet,Hu Process for producing new spiro-pyrazole-square bracket-1,5-d-square bracket closed-square bracket-1,2,4-square bracket closed-triazine derivatives
US4395547A (en) * 1982-02-10 1983-07-26 American Cyanamid Co. Process for preparing 1-substituted-6-n-propyl-8-methylimidazo[1,5-d]-as-triazin-4(3H)-ones
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
ID25871A (id) * 1997-11-12 2000-11-09 Bayer Ag Imidazotriazinon tersubstitusi-2-fenil
DE19827640A1 (de) * 1998-06-20 1999-12-23 Bayer Ag 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone
JP2002523452A (ja) 1998-08-26 2002-07-30 スミスクライン・ビーチャム・コーポレイション 肺疾患の治療方法
PL200923B1 (pl) * 1999-08-21 2009-02-27 Nycomed Gmbh Lek zawierający inhibitor PDE w połączeniu z agonistą receptoraß₂ -adrenergicznego oraz zastosowanie połączenia roflumilastu i salmeterolu
ES2278927T3 (es) * 2001-05-09 2007-08-16 Bayer Healthcare Ag Nuevo uso de imidazotriazinonas de 2-(2-etoxi-5-(4-metil-piperazin-1-sulfonil)-fenil)-5-metil-7-propil-3h-imidazo(5,1-f)(1,2,4)triazin-4-ona.
GB0113344D0 (en) 2001-06-01 2001-07-25 Bayer Ag Novel heterocycles 3
GB0113343D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel Heterocycles 2
DE10135815A1 (de) 2001-07-23 2003-02-06 Bayer Ag Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
ES2326808T3 (es) * 2003-04-01 2009-10-20 Smithkline Beecham Corporation Compuestos de imidazotriazina para el tratamiento de enfermedades cancerosas.
ES2328833T3 (es) 2004-04-02 2009-11-18 Osi Pharmaceuticals, Inc. Inhibidores de proteina quinasa heterobiciclicos con anillo 6,6-biciclico.
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
EP1931797A2 (en) * 2005-09-29 2008-06-18 Bayer HealthCare AG Pde inhibitors and combinations thereof for the treatment of urological disorders
PL1951724T3 (pl) 2005-11-17 2011-09-30 Osi Pharmaceuticals Llc SKONDENSOWANE BICYKLICZNE INHIBITORY mTOR
CA2689638A1 (en) * 2007-06-13 2008-12-18 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of hearing impairment
CN102405214A (zh) 2009-04-20 2012-04-04 Osi药物有限责任公司 C-吡嗪-甲胺的制备
CN103374002B (zh) * 2012-04-19 2015-07-15 山东轩竹医药科技有限公司 磷酸二酯酶-5抑制剂
WO2017000276A1 (en) * 2015-07-01 2017-01-05 Merck Sharp & Dohme Corp. Bicyclic heterocyclic compounds as pde2 inhibitors
WO2017204316A1 (ja) * 2016-05-27 2017-11-30 塩野義製薬株式会社 ５－オキソ－１，２，４－トリアジン誘導体およびその医薬組成物

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4278673A (en) * 1977-03-25 1981-07-14 Allen & Hanburys Limited Pharmacologically active compounds
EP0009384A1 (en) * 1978-09-18 1980-04-02 Glaxo Group Limited Processes for the preparation of triazinones and condensed triazinones, and compounds so obtained
US5498774A (en) * 1989-06-23 1996-03-12 Takeda Chemical Industries, Ltd. Condensed heterocyclic compounds, their production and use
WO2016147659A1 (en) * 2015-03-16 2016-09-22 Sumitomo Dainippon Pharma Co., Ltd. Bicyclic imidazolo derivative

Also Published As

Publication number Publication date
PH9669A (en) 1976-02-10
DK138691C (enrdf_load_stackoverflow) 1979-03-26
ES408736A1 (es) 1976-03-01
FR2160407B1 (enrdf_load_stackoverflow) 1975-10-17
AT321923B (de) 1975-04-25
FR2160407A1 (enrdf_load_stackoverflow) 1973-06-29
IE37046L (en) 1973-05-19
NL7215646A (enrdf_load_stackoverflow) 1973-05-22
CA990292A (en) 1976-06-01
IL40686A (en) 1975-12-31
CH594671A5 (enrdf_load_stackoverflow) 1978-01-13
DK138691B (da) 1978-10-16
DE2255172A1 (de) 1973-05-24
AU4819172A (en) 1974-05-16
AU472127B2 (en) 1976-05-20
JPS563873B2 (enrdf_load_stackoverflow) 1981-01-27
IL40686A0 (en) 1972-12-29
SE402915B (sv) 1978-07-24
JPS4857993A (enrdf_load_stackoverflow) 1973-08-14
ZA727532B (en) 1973-07-25
BE791025A (fr) 1973-05-07
IE37046B1 (en) 1977-04-27
US3840537A (en) 1974-10-08

Similar Documents

Publication Publication Date Title
GB1400999A (en) Imidazo-triazine compounds and their use in therapeutic compositions
NZ208529A (en) 2-pyrimidinyl-1-piperazine derivatives and pharmaceutical compositions
ES2055860T3 (es) Derivados 2-aminopirimidinona.
ES2044836T3 (es) Derivado de la piperidina, su utilizacion y compuesto farmaceutico que lo contiene.
CA2155673A1 (en) N-alkyl-2-substituted atp analogues
ES468525A1 (es) Procedimiento para la obtencion de nuevas 2-alquilenaminodi-hidropiridinas
DE68914292D1 (de) Zusammensetzung zur Behandlung von ischämischen Störungen in Organen.
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
HU170778B (hu) Fungicidnye kompozicii i sposob poluchenija proizvodnykh l-propil-imidazola i soli, to est' soedinenijj primenimykh aktivnymi agentami
ES475633A1 (es) Procedimiento para la obtencion de derivados de 1-n-4,6-di-0-(aminoglicosil)-1,3-diamino-ciclitol.
ATE59632T1 (de) Dihydrodibenzocycloheptylidenethylamin-derivate
GB1507957A (en) Nitrofuryl-pyrazole derivatives methods for producing them and medicaments comprising them
ES439927A1 (es) Procedimiento para la obtencion de 7-metoxi-6-tiatetracicli-nas.
ATE35812T1 (de) Gamma-butyrolactonderivate, verfahren zur herstellung derselben und dieselben als aktive bestandteile enthaltende immunomodulierende zubereitungen.
GB1274809A (en) Evomonoside derivatives
ES478690A1 (es) Procedimiento para la preparacion de derivados de 1,1-dife- nileteno.
DK152053C (da) Analogifremgangsmaade til fremstilling af anthracyclinglycosider eller deres farmaceutiske acceptable syreadditionssalte
ZA839620B (en) Carbamate derivatives,process for their preparation and pharmaceutical compositions containing them
ES473316A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridazinas.
ES424274A1 (es) Procedimiento para la preparacion de 2,4-diamino-5-(3',5'- dimetoxi-4'-metoxialcoxibencil)-pirimidinas.
SE7607856L (sv) Forfarande for framstellning av 2-bensopyranonderivat och deras anvendning som lekemedel
ES441603A1 (es) Procedimiento para preparar composiciones reguladoras del crecimiento de plantas.
MY106235A (en) New 2 - carbonyl substituted n, n'' -di (trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them.
ES474052A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridazinas 1-n-sustituidas.
HU174882B (hu) Sposob poluchenija proizvodnykh 1,12-metanooksimetano-indolo-kvadratnaja skobka-2,3-a-kvadratnaja skobka zakryta-kinolizina i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee